We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Rick Bright, the ex-director of HHS’s Biomedical Advanced Research and Development Authority (BARDA), said yesterday that he was removed from his post because he pushed back against the administration’s promotion of two anti-malaria drugs to treat COVID-19. Read More
The director of HHS’ Biomedical Advanced Research and Development Authority (BARDA), Rick Bright, has departed from the federal vaccine development agency to helm a new initiative on COVID-19 diagnostics at the National Institutes of Health (NIH). Read More
The test uses a drop of blood to detect COVID-19 antibodies in approximately 10 minutes. It can detect both the presence of the virus and a patient’s potential antibody immunity to it. Read More
The FDA hit online pharmacy Unitedpharmacies.md with a warning letter for marketing on its website unapproved and misbranded products as COVID-19 treatments. Read More
The FDA’s Coronavirus Treatment Acceleration Program is gearing up for a second wave of potential COVID-19 treatments and vaccines as the search for effective products gains momentum. Read More
The United Nations adopted a resolution calling for pharma companies to waive exclusive rights for their vaccines and treatments during the COVID-19 crisis. Read More